Cargando…

Diffuse myocardial fibrosis in pediatric hypertrophic cardiomyopathy

Detalles Bibliográficos
Autores principales:	Hussain, Tarique, Dragulescu, Andrea, Benson, Lee, Wong, Derek, Friedberg, Mark, Mertens, Luc, Yoo, Shi-Joon, Grosse-Wortmann, Lars
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3559644/ http://dx.doi.org/10.1186/1532-429X-15-S1-O72

Ejemplares similares

Echocardiography as a Screening Test for Myocardial Scarring in Children with Hypertrophic Cardiomyopathy
por: Compton, Gregory, et al.
Publicado: (2016)

Diffuse myocardial fibrosis using native T1 mapping in children with repaired Tetralogy of Fallot: correlation with surgical factors and exercise capacity
por: Yim, Deane, et al.
Publicado: (2016)

Diffuse myocardial fibrosis in patients after Fontan operation: a T1 relaxometry magnetic resonance pilot study
por: Kato, Atsuko, et al.
Publicado: (2016)

Pediatric Hypertrophic Cardiomyopathy: Exploring the Genotype‐Phenotype Association
por: Nguyen, Minh B., et al.
Publicado: (2022)

MRI in childhood Arrhythmogenic Right Ventricular Cardiomyopathy and proposed modification of the Task Force Criteria for children
por: Grosse-Wortmann, Lars, et al.
Publicado: (2012)

The quantification and role of diffuse myocardial fibrosis in familial dilated cardiomyopathy - an equilibrium contrast cmr study
por: Sado, Daniel M, et al.
Publicado: (2011)

Diffuse myocardial fibrosis in children after heart transplantation
por: Riesenkampff, Eugenie, et al.
Publicado: (2014)

A systematic review for sudden cardiac death in hypertrophic cardiomyopathy patients with myocardial fibrosis: a CMR LGE study
por: Silva, Nackle J, et al.
Publicado: (2012)

In vivo diffusion-weighted MRI detection of myocardial fibrosis in hypertrophic cardiomyopathy patients
por: Nguyen, Christopher T, et al.
Publicado: (2015)

Circulating microRNAs as biomarkers for diffuse myocardial fibrosis in patients with hypertrophic cardiomyopathy
por: Fang, Lu, et al.
Publicado: (2015)

Hypertrophic obstructive cardiomyopathy complicated with acute myocardial infarction and diffuse fibrosis: surgery or not?
por: Wang, Yunhong, et al.
Publicado: (2022)

Myocardial fibrosis in desmin-related hypertrophic cardiomyopathy
por: He, Yi, et al.
Publicado: (2010)

In-vivo T1 cardiovascular magnetic resonance study of diffuse myocardial fibrosis in hypertrophic cardiomyopathy
por: Brouwer, Wessel P, et al.
Publicado: (2014)

Myocardial T2 signal enhancement in hypertrophic cardiomyopathy: prevalence, clinical profile and pathologic correlation
por: Kolman, Louis, et al.
Publicado: (2014)

T(1) mapping for characterization of myocardial fibrosis in hypertrophic cardiomyopathy
por: Liu, Ying, et al.
Publicado: (2016)

Myocardial Fibrosis in Hypertrophic Cardiomyopathy: What Remains to be Proven?
por: Sara, Leonardo
Publicado: (2019)

Native T1 mapping in patients with idiopathic dilated cardiomyopathy for the assessment of diffuse myocardial fibrosis: validation against histologic endomyocardial biopsy
por: Goto, Yoshitaka, et al.
Publicado: (2015)

Contrast-free detection of myocardial fibrosis in hypertrophic cardiomyopathy patients with diffusion-weighted cardiovascular magnetic resonance
por: Nguyen, Christopher, et al.
Publicado: (2015)

Myocardial fibrosis is not associated with reduced quality of life in patients with dilated or hypertrophic cardiomyopathy
por: Khan, Razi, et al.
Publicado: (2011)

Role of T1 and T2-mapping in assessing the myocardial interstitium in hypertrophic cardiomyopathy: a cardiovascular magnetic resonance study
por: Ismail, Tevfik F, et al.
Publicado: (2013)

Progression of myocardial fibrosis in hypertrophic cardiomyopathy: mechanisms and clinical implications
por: Raman, Betty, et al.
Publicado: (2019)

Myocardial Fibrosis in Hypertrophic Cardiomyopathy: A Perspective from Fibroblasts
por: Schlittler, Maja, et al.
Publicado: (2023)

T1 mapping in discrimination between hypertrophic and hypertensive cardiomyopathy
por: Hinojar, Rocio, et al.
Publicado: (2014)

Relative Impact of Right Ventricular Electromechanical Dyssynchrony Versus Pulmonary Regurgitation on Right Ventricular Dysfunction and Exercise Intolerance in Patients After Repair of Tetralogy of Fallot
por: Lumens, Joost, et al.
Publicado: (2019)

Magnetic Resonance Imaging Assessment of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia in Children
por: Yoo, Shi-Joon, et al.
Publicado: (2010)

Low-grade inflammation and the phenotypic expression of myocardial fibrosis in hypertrophic cardiomyopathy
por: Kuusisto, Johanna, et al.
Publicado: (2012)

Clinical significance of late gadolinium enhancement in pediatric patients with hypertrophic cardiomyopathy
por: Smith, Brandon M, et al.
Publicado: (2013)

Diffuse myocardial fibrosis in hypertrophic cardiomyopathy can be identified by cardiovascular magnetic resonance, and is associated with left ventricular diastolic dysfunction
por: Ellims, Andris H, et al.
Publicado: (2012)

Combined ventricular output and oxygen delivery are reduced while oxygen extraction fraction is increased in fetuses with Ebstein's Anomaly by MRI
por: Zhu, Meng Yuan, et al.
Publicado: (2016)

Myocardial contractile response to dobutamine in hypoplastic left heart syndrome post-Fontan
por: Wong, James, et al.
Publicado: (2014)

An Unusual Presentation of a Myocardial Crypt in Hypertrophic Cardiomyopathy
por: van de Sande, Danny A. J. P., et al.
Publicado: (2014)

Examining the impact of inducible ischemia on myocardial fibrosis and exercise capacity in hypertrophic cardiomyopathy
por: Malahfji, Maan, et al.
Publicado: (2020)

Genotype-Related Clinical Characteristics and Myocardial Fibrosis and Their Association with Prognosis in Hypertrophic Cardiomyopathy
por: Kim, Hyung Yoon, et al.
Publicado: (2020)

Effect of sarcomere and mitochondria-related mutations on myocardial fibrosis in patients with hypertrophic cardiomyopathy
por: Chung, Hyemoon, et al.
Publicado: (2021)

Incremental predictive value of deep crypts in the basal inferoseptum in the setting of hypertrophic cardiomyopathy
por: Deva, Djeven P, et al.
Publicado: (2013)

Preclinical alterations in cardiac energetics amongst sarcomere mutation carriers in hypertrophic cardiomyopathy
por: Lloyd, Rachael, et al.
Publicado: (2015)

T2 abnormalities in patients with hypertrophic cardiomyopathy characterized by cardiovascular magnetic resonance imaging- an indicator of myocardial injury as assessed by the high sensitive cardiac troponin T assay
por: Lehrke, Stephanie, et al.
Publicado: (2012)

Quantitative of myocardial extracellular volume fraction improves characterization of fibrotic burden in patients with apical hypertrophic cardiomyopathy beyond visual assessment with late gadolinium enhancement
por: Watanabe, Eri, et al.
Publicado: (2012)

Exercise and myocardial injury in hypertrophic cardiomyopathy
por: Cramer, G Etienne, et al.
Publicado: (2020)

Interrelationship of LV mass, focal fibrosis by LGE, and diffuse fibrosis by T1-changes in patients with hypertrophic cardiomyopathy
por: Potluri, Rahul, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_vm98v4n0k95rpvlrd8d1sluu4h